Tumor Ablation by Irreversible Electroporation (IRE) Augments CTLA-4 Checkpoint Inhibitor Immunotherapy

Authors :: Meagan R. Rollins
Katharine M. Young
Samira M. Azarin
Meredith Song
Brandon J. Burbach
Qi Shao
Yoji Shimizu
John C. Bischof
Stephen D O'Flanagan
Joseph R. Slaughter
Source :: Journal of the American College of Surgeons. 229:e204
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: CTLA-4
business.industry
Immune checkpoint inhibitors
medicine.medical_treatment
medicine
Cancer research
Surgery
Immunotherapy
Irreversible electroporation
business
Tumor ablation

Full Text Access

Tools